| Course | IHP 515 Population-Based Epidemiology |
|---|---|
| Module | Module 9 |
| Paper type | final epidemiologic profile and recommendations |
| Length | About 1,000 words, 6 pages |
| Format | APA 7 student paper |
| School | Southern New Hampshire University |
| Program | MPH |
| Updated | September 2026 |
Free sample paper for IHP 515 Module 9
Opioid Overdose Deaths in Harlan County: An Epidemiologic Profile and Recommendations for Prevention
[Student Name]
Southern New Hampshire University
IHP 515: Population-Based Epidemiology
Module Nine Final Project
[Instructor Name]
[Date]
Opioid Overdose Deaths in Harlan County: An Epidemiologic Profile and Recommendations for Prevention
Executive Summary
Across Harlan, the composite county profiled here, yearly opioid overdose deaths climbed from the high thirties to the low seventies between 2019 and 2023, nearly doubling the death rate, as fentanyl came to be detected in close to four of every five deaths. Risk peaked in young and middle-aged adults and in men, and was especially high for people just out of jail, people with a prior nonfatal overdose and residents of the county's poorest area, and rates rose fastest among Black residents. Most people died at home and alone. The evidence supports broad naloxone distribution, medication treatment begun during emergency visits and before people leave custody and better surveillance, with specific targets and monitoring.
Context
Rudd et al. (2016) documented a steep national rise in overdose deaths, with opioid-involved deaths growing fastest and the recent surge driven by heroin and synthetic opioids such as illicit fentanyl. Harlan's experience follows that national arc a few years later: stable rates through 2019, then annual increases coinciding with fentanyl's arrival in local drug markets and with disruptions during the pandemic.
Descriptive Findings
The crude death rate climbed each year from 2019 through 2023, reaching about 34 per 100,000, and a simplified age adjustment showed Harlan's burden exceeding that of a younger neighboring county whose crude rate appeared higher. Adults aged 25 to 44 had a 2023 rate of about 75 per 100,000. Men accounted for nearly three quarters of deaths. Rates among Black residents roughly tripled over the period and overtook those among white residents. By place, the Eastside area, marked by high poverty and a major plant closure, reached 58 per 100,000. Nearly a quarter of decedents had left incarceration within the prior year, about three in ten had survived an earlier overdose within twelve months and fewer than one in five had recent medication treatment. Most died in a residence, and in over two in five deaths no one else was present.
Causal Reasoning
Several causes appear to act together. Fentanyl's spread through the local drug supply is the most likely driver of the county-wide rise, given the parallel increase in fentanyl detection across groups and areas. The 2020 closure of the county's treatment program probably contributed to some deaths among its former patients but explains only a small share of the rise, since deaths increased among non-patients and in neighboring counties too. Jail release without treatment and prior nonfatal overdose mark periods of very high risk. The faster rise among Black residents likely reflects differences in the timing of fentanyl's arrival in certain markets and in treatment access, rather than individual behavior. These conclusions rest on observational data and are subject to confounding, which the planned analyses will examine.
A Population and High-Risk Strategy
Rose (1985) argued that when a risk factor is widespread, a population strategy that shifts risk for everyone can prevent more deaths than focusing only on the highest-risk individuals. Fentanyl contamination affects nearly everyone who uses illicit drugs in Harlan, so population-wide measures such as broad naloxone availability are essential. At the same time, the descriptive data identify moments of extreme risk, after jail release and after a nonfatal overdose, where targeted action can have outsized benefit. The recommendations combine both strategies.
Evidence for Recommended Actions
Walley et al. (2013) found in an interrupted time series across Massachusetts communities that overdose education and naloxone distribution were associated with lower overdose death rates, with larger reductions where more people were reached. Larochelle et al. (2018) followed overdose survivors and found that methadone and buprenorphine in the following year were associated with substantially lower mortality. Both findings come from observational designs, but their consistency, dose-response patterns and clear mechanisms support action.
Recommendations
First, distribute naloxone widely, including mailed kits, pharmacy standing orders, distribution at jail release and emergency departments and outreach to households and rural areas where people use alone. Second, start buprenorphine in emergency departments for patients after overdose and before release from jail, with a warm handoff to community treatment. Third, restore and protect treatment capacity, including a plan to keep medication available during emergencies. Fourth, expand outreach in the Eastside area and among Black residents through trusted community partners. Fifth, strengthen surveillance as described below.
Table 1. Recommendations, Targets and Measures
| Recommendation | Target by end of 2025 | Measure |
|---|---|---|
| Broad naloxone distribution | 10,000 kits distributed per year | Kits distributed; bystander administrations |
| Treatment started in emergency departments and jail | 50% of overdose patients and releases offered buprenorphine | Share offered and started |
| Protect treatment capacity | Emergency continuity plan in place | Plan adopted; treatment slots |
| Targeted outreach | Outreach partners active in Eastside and Black communities | Contacts; treatment referrals |
| Strengthened surveillance | Syndromic alerts and standard toxicology | Alert timeliness; complete records |
Note. Targets are illustrative and should be set with community partners.
Surveillance and Evaluation
Thacker and Berkelman (1988) describe surveillance as continuing, organized data work that supports planning and evaluation and must reach those who can act. Harlan will add near-real-time emergency department alerts, standardize toxicology testing, link death, jail, treatment and pharmacy records and publish a monthly dashboard. The primary outcome for evaluating the recommendations is the age-adjusted overdose death rate, tracked quarterly and compared with state trends, with secondary measures for each recommendation and results reported by race and area to confirm that gaps are narrowing.
Limitations
County rates rest on small numbers and are unstable, especially for subgroups. Death certificates varied in completeness before toxicology was standardized. Causal conclusions are qualified by possible confounding, and the evidence for interventions comes from other settings. The profile should be updated annually as new data arrive.
Estimates of subgroup trends will be revisited with pooled multiyear data before any subgroup-specific targets are finalized.
Conclusion
Harlan County's overdose crisis follows the national shift to fentanyl but falls unequally, concentrating in moments and places of high risk. Epidemiologic description, careful causal reasoning and evidence from other communities point to a clear response: make naloxone ubiquitous, start treatment at the moments of greatest risk, protect treatment capacity, reach the most affected communities and measure whether deaths fall.
References
Larochelle, M. R., Bernson, D., Land, T., Stopka, T. J., Wang, N., Xuan, Z., Bagley, S. M., Liebschutz, J. M., & Walley, A. Y. (2018). Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: A cohort study. Annals of Internal Medicine, 169(3), 137-145. https://doi.org/10.7326/M17-3107
Rose, G. (1985). Sick individuals and sick populations. International Journal of Epidemiology, 14(1), 32-38. https://doi.org/10.1093/ije/14.1.32
Rudd, R. A., Aleshire, N., Zibbell, J. E., & Gladden, R. M. (2016). Increases in drug and opioid overdose deaths: United States, 2000-2014. MMWR. Morbidity and Mortality Weekly Report, 64(50-51), 1378-1382. https://doi.org/10.15585/mmwr.mm6450a3
Thacker, S. B., & Berkelman, R. L. (1988). Public health surveillance in the United States. Epidemiologic Reviews, 10(1), 164-190. https://doi.org/10.1093/oxfordjournals.epirev.a036021
Walley, A. Y., Xuan, Z., Hackman, H. H., Quinn, E., Doe-Simkins, M., Sorensen-Alawad, A., Ruiz, S., & Ozonoff, A. (2013). Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: Interrupted time series analysis. BMJ, 346, Article f174. https://doi.org/10.1136/bmj.f174
What the IHP 515 Module 9 instructions ask for
The IHP 515 final project usually asks for a complete epidemiologic profile of a population health problem: descriptive findings, analytic reasoning, evidence for interventions, recommendations and a plan for surveillance and evaluation. Expect ten to fifteen APA 7 pages. Present rates rather than counts, keep numbers consistent with earlier milestones, qualify causal claims and tie each recommendation to both the data and the evidence. Include measurable targets, report outcomes by group and area and acknowledge limitations. Instructors value profiles that a health department could actually hand to its board, so write clearly for decision makers. IHP 515 graders notice clean headings in IHP 515 papers. IHP 515 names and dates need checking before IHP 515 submission.
How this IHP 515 Module 9 final project example is built
This final profile describes a composite county's opioid overdose deaths, which nearly doubled as fentanyl reached close to four in five deaths, with risk concentrated among adults aged 25 to 44, men, people leaving jail, those with prior overdoses and the poorest area, and rising fastest among Black residents. Rudd and colleagues frame the national context, qualified causal reasoning weighs fentanyl, a clinic closure and jail release and Rose's framework supports combined population and targeted strategies. Walley and colleagues and Larochelle and colleagues support naloxone and treatment. Five recommendations with targets, surveillance and evaluation by group complete it. IHP 515 students can reuse this structure for IHP 515 work. IHP 515 claims here trace to cited IHP 515 sources.
Where the IHP 515 Module 9 rubric puts the points
Final epidemiologic profiles in IHP 515 are commonly judged on accurate descriptive findings, sound causal reasoning, use of evidence, recommendations tied to data, measurable targets, surveillance and evaluation plans, attention to disparities, limitations, clarity for decision makers and APA 7. The best profiles read as one argument from data to action and qualify claims appropriately. Profiles lose points when numbers conflict with earlier work, when recommendations do not follow from findings or when causal statements outrun the evidence. Reporting outcomes by group and place is often credited as essential. IHP 515 marks favor careful formatting across IHP 515 sections. IHP 515 citations keep every IHP 515 argument credible.
IHP 515 Module 9 help: the mistakes that cost points
In IHP 515, capstone profiles commonly drop points for stitched-together milestones, inconsistent rates, overstated causal claims and recommendations without targets or measures. Another frequent weak spot is writing for epidemiologists rather than for the decision makers who will read the report. Revise into one profile, keep numbers aligned, qualify causation, tie recommendations to data and evidence, set targets and plan evaluation by group. If your instructor wants a particular report format, such as an executive brief plus technical appendix, add that to your IHP 515 notes. IHP 515 drafts start well from a IHP 515 outline. IHP 515 feedback already received guides IHP 515 revisions.
Get IHP 515 Module 9 written to your instructions
Send the IHP 515 final project instructions and your milestones. The profile will be revised into one report with consistent rates, qualified causal reasoning, evidence-based recommendations with targets and a surveillance and evaluation plan by group, within 24 to 48 hours, free the first time. The paper above is an original model document written by our desk, not a submitted student paper and not an official Southern New Hampshire University document.
More IHP 515 papers and related MPH samples
- IHP 515 Module 1 Discussion: Sick Individuals and Sick Populations
- IHP 515 Module 2 Measures Paper: Counts, Rates, Incidence, Prevalence and Age Adjustment
- IHP 515 Module 3 Milestone One: Describing the Overdose Crisis by Person, Place and Time
- IHP 515 Module 4 Study Design Paper: Cohort and Case-Control Studies
- IHP 515 Module 5 Milestone Two: Evidence on Naloxone Distribution and Treatment After Overdose
- IHP 515 Module 6 Causation Paper: Association, Causation, Bias and Confounding
- IHP 515 Module 7 Milestone Three: A Surveillance and Analysis Plan for Overdose Deaths
- IHP 515 Module 8 Outbreak Investigation Paper: Investigating a Salmonella Cluster After a Spring Festival
- IHP 501 Module 6 Cultural Humility Paper: Cultural Competence, Cultural Humility and What Training Achieves
- IHP 505 Module 10 Journal: Leading from the Front Line
- IHP 510 Module 1 Discussion: Marketing a Hospital Versus Marketing a Health Behavior
- IHP 340 Module 4 Confidence Interval Journal
IHP 515 Module 9 questions, answered
Where can I find a free IHP 515 Module 9 Final Project sample?
Everything is on this page: an epidemiologic profile of opioid overdose deaths with causal reasoning, recommendations, targets and evaluation.
What belongs in an epidemiologic profile?
Descriptive findings by time, person and place, analytic reasoning, evidence for interventions, recommendations, surveillance and limitations.
Why combine population and high-risk strategies?
Widespread risks need population-wide measures, while moments of extreme risk, such as jail release, benefit from targeted action.
What interventions reduce opioid overdose deaths?
Evidence supports broad naloxone distribution and medication treatment such as methadone and buprenorphine, especially after overdose.
How should an overdose prevention plan be evaluated?
Track age-adjusted death rates over time against state trends, with measures for each intervention and results by group and area.